Acadia Healthcare Company Inc. held its annual meeting of stockholders on May 29, 2025. The stockholders elected Jason R. Bernhard, William F. Grieco, R. David Kelly, and Reeve B. Waud as Class II directors. An amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan was approved. The appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. Additionally, a majority of stockholders selected a one-year frequency for non-binding advisory votes on executive compensation.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.